Clinical development of a new inactivated hepatitis A vaccine.
Vidor
E
E
Pasteur Mérieux Connaught, Medical Affairs, Swiftwater, PA 18370, USA.
Fritzell
B
B
Plotkin
S
S
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D004306:Dose-Response Relationship, Immunologic; D004353:Drug Evaluation, Preclinical; D005260:Female; D022362:Hepatitis A Vaccines; D006507:Hepatovirus / Q000276:immunology; D006801:Humans; D008297:Male; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage / Q000276:immunology*
D000914:Antibodies, Viral; D022362:Hepatitis A Vaccines; D014761:Viral Hepatitis Vaccines